HHealth care Read More Amgen vs. Moderna: Which Healthcare Stock Is a Better Buy in 2026?September 14, 2026 Should you bet on an established giant or a pipeline-driven innovator? This comparison examines Amgen (NASDAQ:AMGN) and Moderna…
MMedication Read More ‘No longer proven to outweigh its risks’: Ireland pulls medication linked to 20 deaths in JapanAugust 28, 2026 A medication used to treat rare autoimmune diseases has been pulled from shelves in Ireland after regulators revisited…
MMedication Read More Colorado can’t cap price of arthritis drug Enbrel, judge rulesJuly 7, 2026 Colorado can’t cap the price of arthritis medication Enbrel while a lawsuit challenging the state’s drug affordability board’s…
MMedication Read More Nearly 1 million bottles of heart, kidney medications recalled nationwide over ‘foreign substance’July 3, 2026 Testing that raised concerns about possible foreign contamination has triggered a recall in the United States of nearly…
MMedication Read More Colorado receives FDA permission to import drugs from CanadaJune 16, 2026 Colorado finally has federal permission to start importing cheaper prescription drugs from Canada, but the state may not…
MMedication Read More The next goal for weight loss drugs? Fewer injectionsJune 8, 2026 For millions of people taking weight loss drugs, the next breakthrough may not be more weight loss. It…
HHealth care Read More 9 big pharmaceutical companies agree to lower drug prices for MedicaidDecember 23, 2025 U.S. President Donald Trump announced Friday that nine drugmakers have agreed to lower the cost of their prescription…
BBusiness Read More Amgen’s Repatha cholesterol shot slashed heart attack risk by 36%November 8, 2025 Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach…
JJobs Read More These 20 companies still love remote workSeptember 25, 2025 Across much of America, workers fear their options for remote work are slipping away. The news cycle churns…
MMedication Read More REPATHA® NOW INDICATED FOR ADULTS AT INCREASED RISK FOR MAJOR ADVERSE CARDIOVASCULAR EVENTS DUE TO UNCONTROLLED LDL-CAugust 27, 2025 THOUSAND OAKS, Calif., Aug. 25, 2025 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug…